212 related articles for article (PubMed ID: 24205439)
1. AIDS-Related Non-Hodgkin's Lymphoma in Sub-Saharan Africa: Current Status and Realities of Therapeutic Approach.
Mwamba PM; Mwanda WO; Busakhala N; Strother RM; Loehrer PJ; Remick SC
Lymphoma; 2012; 2012():. PubMed ID: 24205439
[TBL] [Abstract][Full Text] [Related]
2. Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.
Mwanda WO; Orem J; Fu P; Banura C; Kakembo J; Onyango CA; Ness A; Reynolds S; Johnson JL; Subbiah V; Bako J; Wabinga H; Abdallah FK; Meyerson HJ; Whalen CC; Lederman MM; Black J; Ayers LW; Katongole-Mbidde E; Remick SC
J Clin Oncol; 2009 Jul; 27(21):3480-8. PubMed ID: 19470940
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa.
Otieno MW; Banura C; Katongole-Mbidde E; Johnson JL; Ghannoum M; Dowlati A; Renne R; Arts E; Whalen C; Lederman MM; Remick SC
J Natl Cancer Inst; 2002 May; 94(10):718-32. PubMed ID: 12011222
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.
; Bohlius J; Schmidlin K; Costagliola D; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Karafoulidou A; Miro JM; Lundgren J; Chene G; Egger M
Antivir Ther; 2009; 14(8):1065-74. PubMed ID: 20032536
[TBL] [Abstract][Full Text] [Related]
5. Hiv and Lymphoma: from Epidemiology to Clinical Management.
Re A; Cattaneo C; Rossi G
Mediterr J Hematol Infect Dis; 2019; 11(1):e2019004. PubMed ID: 30671210
[TBL] [Abstract][Full Text] [Related]
6. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
[TBL] [Abstract][Full Text] [Related]
7. AIDS-associated cancer in developing nations.
Orem J; Otieno MW; Remick SC
Curr Opin Oncol; 2004 Sep; 16(5):468-76. PubMed ID: 15314517
[TBL] [Abstract][Full Text] [Related]
8. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
9. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms.
Franceschi S; Dal Maso L; La Vecchia C
Int J Cancer; 1999 Nov; 83(4):481-5. PubMed ID: 10508483
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy.
Grulich AE
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S27-30. PubMed ID: 10430215
[TBL] [Abstract][Full Text] [Related]
12. AIDS-related systemic non-Hodgkin's lymphoma at a large community program.
Vilchez RA; Kozinetz CA; Jorgensen JL; Kroll MH; Butel JS
AIDS Res Hum Retroviruses; 2002 Mar; 18(4):237-42. PubMed ID: 11860669
[TBL] [Abstract][Full Text] [Related]
13. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.
Jacobson LP; Yamashita TE; Detels R; Margolick JB; Chmiel JS; Kingsley LA; Melnick S; Muñoz A
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S34-41. PubMed ID: 10430217
[TBL] [Abstract][Full Text] [Related]
14. AIDS-related lymphomas in Nigeria.
Bolarinwa RA; Ndakotsu MA; Oyekunle AA; Salawu L; Akinola NO; Durosinmi MA
Braz J Infect Dis; 2009 Oct; 13(5):359-61. PubMed ID: 20428636
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
17. Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma.
Rochford R; Feuer G; Orem J; Banura C; Katongole-Mbidde E; Mwanda WO; Moormann A; Harrington WJ; Remick SC
East Afr Med J; 2005 Sep; 82(9 Suppl):S155-60. PubMed ID: 16619692
[TBL] [Abstract][Full Text] [Related]
18. Human Immunodeficiency Virus Infection and Hodgkin's Lymphoma in South Africa: An Emerging Problem.
Patel M; Philip V; Fazel F
Adv Hematol; 2011; 2011():578163. PubMed ID: 21331149
[TBL] [Abstract][Full Text] [Related]
19. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.
Eltom MA; Jemal A; Mbulaiteye SM; Devesa SS; Biggar RJ
J Natl Cancer Inst; 2002 Aug; 94(16):1204-10. PubMed ID: 12189223
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
